Improvement of solubility and targetability of radioiodinated hypericin by using sodium cholate based solvent in rat models of necrosis

References

• Chen B, Xu Y, Roskams T, et al. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 2001;93:275–82
   PubMed Web of Science ®Google Scholar
• Van de Putte M, Roskams T, Vandenheede JR, et al. Elucidation of the tumoritropic principle of hypericin. Br J Cancer 2005;92:1406–13
   PubMed Web of Science ®Google Scholar
• Xie X, Hudson JB, Guns ES. Tumor-specific and photodependent cytotoxicity of hypericin in the human LNCaP prostate tumor model. Photochem Photobiol 2001;74:221–5
   PubMed Web of Science ®Google Scholar
• Lavie G, Mazur Y, Lavie D, et al. The chemical and biological properties of hypericin – a compound with a broad spectrum of biological activities. Med Res Rev 1995;15:111–19
   PubMed Web of Science ®Google Scholar
• Kubin A, Meissner P, Wierrani F, et al. Fluorescence diagnosis of bladder cancer with new water soluble hypericin bound to polyvinylpyrrolidone: PVP–hypericin. Photochem Photobiol 2008;84:1560–3
   PubMedGoogle Scholar
• Chen B, Zupko I, de Witte PA. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy. Int J Oncol 2001;18:737–42
   PubMed Web of Science ®Google Scholar
• Zaak D, Karl A, Knüchel R, et al. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU Int 2005;96:217–22
   PubMed Web of Science ®Google Scholar
• Van de Putte M, Wang H, Chen F, et al. Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model. Acad Radiol 2008;15:107–13
   PubMed Web of Science ®Google Scholar
• Li J, Cona MM, Chen F, et al. Exploring theranostic potentials of radioiodinated hypericin in rodent necrosis models. Theranostics 2012;2:1010--19
   PubMed Web of Science ®Google Scholar
• Van de Putte M, Wang H, Chen F, et al. Hypericin as a marker for determination of tissue viability after radiofrequency ablation in a murine liver tumor model. Oncol Rep 2008;19:927–32
   PubMed Web of Science ®Google Scholar
• Van de Putte M, Marysael T, Fonge H, et al. Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential. Int J Cancer 2012;131:129–37
   PubMed Web of Science ®Google Scholar
• Song S, Xiong C, Zhou M, et al. Small-animal PET of tumor damage induced by photothermal ablation with 64cu-bis-dota-hypericin. J Nucl Med 2011;52:792–9
   PubMed Web of Science ®Google Scholar
• Marysael T, Bauwens M, Ni Y, et al. Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy. Invest New Drug 2012;30:2132–40
   PubMed Web of Science ®Google Scholar
• Li J, Cona MM, Chen F, et al. Sequential systemic administrations of combretastatin A4 Phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts. Theranostics 2013;3:127–37
   PubMed Web of Science ®Google Scholar
• Li J, Sun Z, Zhang J, et al. A dual-targeting anticancer approach: soil and seed principle. Radiology 2011;260:799–807
   PubMed Web of Science ®Google Scholar
• Ni Y, Huyghe D, Verbeke K, et al. First preclinical evaluation of mono-[123 I] iodohypericin as a necrosis-avid tracer agent. Eur J Nucl Med Mol I 2006;33:595–601
   PubMed Web of Science ®Google Scholar
• Bánó G, Staničová J, Jancura D, et al. On the diffusion of hypericin in dimethylsulfoxide/water mixtures – the effect of aggregation. J Phys Chem B 2011;115:2417–23
   PubMed Web of Science ®Google Scholar
• Miranda Cona M, Li J, Feng Y, et al. Targetability and biodistribution of radioiodinated hypericin: comparison between microdosing and carrier-added preparations. Anti-Cancer Agents Med Chem 2013 Aug 28 . [Epub ahead of print]
   Web of Science ®Google Scholar
• Van De Putte M, Roskams T, Bormans G, et al. The impact of aggregation on the biodistribution of hypericin. Int J Oncol 2006;28:655--60
   PubMed Web of Science ®Google Scholar
• Pal R, Mamidi MK, Das AK, et al. Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation potential of human embryonic stem cells. Arch Toxicol 2012;86:651–61
   PubMed Web of Science ®Google Scholar
• Guo J, Wu T, Ping Q, et al. Solubilization and pharmacokinetic behaviors of sodium cholate/lecithin-mixed micelles containing cyclosporine A. Drug Deliv 2004;12:35–9
   Web of Science ®Google Scholar
• Sugioka H, Moroi Y. Micelle formation of sodium cholate and solubilization into the micelle. BBA-L L Met 1998;1394:99–110
   PubMed Web of Science ®Google Scholar
• Arteaga CL, Brown TD, Kuhn JG. Phase I clinical and pharmacokinetic trial of brequinar sodium. Cancer Res 1989;49:4648–53
   PubMed Web of Science ®Google Scholar
• Wang J, Yang W, Jiang L, et al. Study on the interaction of sodium cholate with supported bilayer lipid membrane by electrochemistry method. Chem J Chin Univ 2007;28:859–61
   Web of Science ®Google Scholar
• Sun ZP, Yicheng N. Iodogen method for preparation of radioiodinated hypericin. Patent CN 200910013998; 2009
   Google Scholar
• Ni Y, Adzamli K, Miao Y, et al. MRI contrast enhancement of necrosis by MP-2269 and gadophrin-2 in a rat model of liver infarction. Invest Radiol 2001;36:97–103
   PubMed Web of Science ®Google Scholar
• Ni Y, Petré C, Miao Y, et al. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis. Invest Radiol 1997;32:770--9
   PubMed Web of Science ®Google Scholar
• Wang H, Sun X, Chen F, et al. Treatment of rodent liver tumor with combretastatin a4 phosphate: noninvasive therapeutic evaluation using multiparametric magnetic resonance imaging in correlation with microangiography and histology. Invest Radiol 2009;44:44–53
   PubMed Web of Science ®Google Scholar
• Paternostre MT, Roux M, Rigaud JL. Mechanisms of membrane protein insertion into liposomes during reconstitution procedures involving the use of detergents. 1. Solubilization of large unilamellar liposomes (prepared by reverse-phase evaporation) by triton X-100, octyl glucoside, and sodium cholate. Biochemistry 1988;27:2668–77
   PubMed Web of Science ®Google Scholar
• Yu JN, Zhu Y, Wang L, et al. Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles. Acta Pharmacol Sin 2010;31:759–64
   PubMed Web of Science ®Google Scholar
• Chattopadhyay A, London E. Fluorimetric determination of critical micelle concentration avoiding interference from detergent charge. Anal Biochem 1984;139:408–12
   PubMed Web of Science ®Google Scholar
• Zhang X, Jackson JK, Burt HM. Determination of surfactant critical micelle concentration by a novel fluorescence depolarization technique. J Biochem Biophys Meth 1996;31:145–50
   PubMedGoogle Scholar
• Butterweck V, Liefländer-Wulf U, Winterhoff H, et al. Plasma levels of hypericin in presence of procyanidin B2 and hyperoside: a pharmacokinetic study in rats. Planta Med 2003;69:189–92
   PubMed Web of Science ®Google Scholar
• Basu S, Binder RJ, Suto R, et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Planta Med 2000;12:1539–46
   Google Scholar
• Sauter B, Albert ML, Francisco L, et al. Consequences of cell death exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000;191:423–34
   PubMed Web of Science ®Google Scholar
• Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002;20:395–425
   PubMed Web of Science ®Google Scholar
• Van de Putte M, Ni YC, De Witte PA. Exploration of the mechanism underlying the tumor necrosis avidity of hypericin. Oncol Rep 2008;19:921–6
   PubMed Web of Science ®Google Scholar
• Roelants M, Van Cleynenbreugel B, Lerut E, et al. Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids. Photochem Photobiol Sci 2011;10:151–9
   PubMed Web of Science ®Google Scholar